Want to join the conversation?
New York-based biopharmaceutical firm $BMY posted 4Q15 net loss attributable to the company of $138MM or $0.08 per share, hurt by higher expenses. This compared to net earnings of $13MM or $0.01 per share in 4Q14. Revenue of $4.3Bil grew 1% compared to last year. Non-GAAP net earnings attributable to $BMY were $647MM or $0.38 per share in 4Q15.
What are your expectations from $COKE tomorrow?? Will the bear attack the beverage?
People seem to be cold about the $HAL earnings! Honestly, I expected more stock action by now.
$TSLA's Musk says Neuralink will take on AI prominence. Apparently, he wants to avoid a "Terminator" kind situation.
$JCP shares rebounded and now in green territory after saying it will hire 800 consultants as part of a beauty expansion that will include 70 new Sephora store-in-store locations.